Silicon Valley Cardiology

State of the Art Cardiac Care in the San Francisco Bay Area

  • Home
  • Physicians
    • Roger Winkle
    • R. Hardwin Mead
    • Nellis A. Smith
    • Bruce A. Benedick
    • Donald A. St. Claire, Jr
    • Rob A. Patrawala
    • Gregory Engel
    • Chad Brodt
    • Jonathan Salcedo
    • Shalini Bhambani
    • Shadi Kalantarian
  • Services
  • Atrial Fibrillation Center
  • Publications
  • New Patient?
  • Contact
home  »  Publications

Publications

Publications

For your interest,  below are some of the more recent publications from the physicians of Silicon Valley Cardiology

Predicting atrial fibrillation ablation outcome: The CAAP-AF score
Winkle RA, Jarman, JWE, Mead RH, Engel G, Kong, MA, Fleming, W, Patrawala RA.
Heart Rhythm, vol. 13, p 2119-2125, Nov. 2016
Ablation of atypical atrial flutters using ultra high density-activation sequence mapping
Winkle RA, Moskowitz, R, Mead RH, Engel G, Kong, MA, Fleming, W, Patrawala RA.
Journal of Interventional Cardiac Electrophysiology , p. 1-8,Nov. 2016
Gender Differences of Thromboembolic Events in Atrial Fibrillation
Cheng, EY, Kong, MA.
Am J Cardiol 2016;117:1021-1027
Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban
Winkle RA, Mead RH, Engel G, Kong, MA, Patrawala RA.
Europace (2014) 16 (10): 1443-1449.
Atrial fibrillation ablation using open-irrigated tip radiofrequency: Experience with intraprocedural activated clotting times ≤210 seconds
Winkle RA, Mead RH, Engel G, Kong, MA, Patrawala RA.
Heart Rhythm
Volume 11, Issue 6, Pages 963–968, June 2014
Comparison of CHADS2 and CHA2DS2-VASC anticoagulation recommendations: evaluation in a cohort of atrial fibrillation ablation patients
Winkle RA, Mead RH, Engel G, Kong, MA, Patrawala RA.
Europace (2014) 16 (2): 195-201.
Discontinuing anticoagulation following successful atrial fibrillation ablation in patients with prior strokes
Winkle RA, Mead RH, Engel G, Kong, MA, Patrawala RA.
Journal of Interventional Cardiac Electrophysiology December 2013, Volume 38, Issue 3, pp 147-153,
Physician-controlled costs: the choice of equipment used for atrial fibrillation ablation
Winkle RA, Mead RH, Engel G, Kong, MA, Patrawala RA.
Journal of Interventional Cardiac Electrophysiology. 2013 1-9
Trends in atrial fibrillation ablation: have we maximized the current paradigms?
Winkle RA, Mead RH, Engel G, Kong, MA, Patrawala RA.
Journal of Interventional Cardiac Electrophysiology. 2012 34(2)115-123
Prior antiarrhythmic drug use and the outcome of atrial fibrillation ablation
Winkle RA, Mead RH, Engel G, Kong, MA, Patrawala RA.
EP Europace. 2012 14:646-652
The use of a radiofrequency needle improves the safety and efficacy of transseptal puncture for atrial fibrillation ablation.
Winkle RA, Mead RH, Engel G, Patrawala RA.
Heart Rhythm. 2011 Sep;8(9):1411-5. Epub 2011 May 6.
Atrial Arrhythmia Burden on Long-Term Monitoring in Asymptomatic Patients Late After Atrial Fibrillation Ablation.
Winkle RA, Mead RH, Engel G, Kong, MA, Patrawala RA.
Am. J. Cardiology 2012 110:840-844
Relation of early termination of persistent atrial fibrillation by cardioversion or drugs to ablation outcomes.
Winkle RA, Mead RH, Engel G, Patrawala RA.
Am J Cardiol. 2011 Aug 1;108(3):374-9. Epub 2011 May 19.
Atrial fibrillation ablation: “perpetual motion” of open irrigated tip catheters at 50 W is safe and improves outcomes.
Winkle RA, Mead RH, Engel G, Patrawala RA.
Pacing Clin Electrophysiol. 2011 May;34(5):531-9. doi: 10.1111/j.1540-8159.2010.02990.x. Epub 2011 Jan 5.
Safety of lower activated clotting times during atrial fibrillation ablation using open irrigated tip catheters and a single transseptal puncture.
Winkle RA, Mead RH, Engel G, Patrawala RA.
Am J Cardiol. 2011 Mar 1;107(5):704-8. Epub 2010 Dec 22.
The Use of Dabigatran Immediately After Atrial Fibrillation Ablation.
Winkle RA, Mead RH, Engel G, Kong MH, Patrawala RA.
J Cardiovasc Electrophysiol. 2011 Sep 28. doi: 10.1111/j.1540-8167.2011.02175.x. [Epub ahead of print]
Evolution of the Implantable Cardioverter-Defibrillator
Winkle, RA
J Amer College of Cardiology 2012 60:2399-2401
Outcomes registry for better informed treatment of atrial fibrillation: rationale and design of ORBIT-AF. Piccini JP, Fraulo ES, Ansell JE, Fonarow GC, Gersh BJ, Go AS, Hylek EM, Kowey PR, Mahaffey KW, Thomas LE, Kong MH, Lopes RD, Mills RM, Peterson ED. Am Heart J. 2011 Oct;162(4):606-612.e1.
The effectiveness and cost effectiveness of public-access defibrillation.
Winkle RA.
Clin Cardiol. 2010 Jul;33(7):396-9. Review.
The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts.
Crossley GH, Boyle A, Vitense H, Chang Y, Mead RH; CONNECT Investigators.
J Am Coll Cardiol. 2011 Mar 8;57(10):1181-9. Epub 2011 Jan 20.
Chronic performance of an active fixation coronary sinus lead.
Crossley GH, Exner D, Mead RH, Sorrentino RA, Hokanson R, Li S, Adler S; Medtronic 4195 Study Investigators.
Heart Rhythm. 2010 Apr;7(4):472-8. Epub 2010 Jan 11.
Trial design of the clinical evaluation of remote notification to reduce time to clinical decision: the Clinical evaluation Of remote NotificatioN to rEduCe Time to clinical decision (CONNECT) study.
Crossley G, Boyle A, Vitense H, Sherfesee L, Mead RH.
Am Heart J. 2008 Nov;156(5):840-6. Epub 2008 Sep 11.
Remote monitoring for atrial fibrillation.
Engel G, Mead RH.
Congest Heart Fail. 2008 Sep-Oct;14(5 Suppl 2):14-8. Review.
Characterization of human coronary sinus valves by direct visualization during biventricular pacemaker implantation.
Anh DJ, Eversull CS, Chen HA, Mofrad P, Mourlas NJ, Mead RH, Zei PC, Hsia HH, Wang PJ, Al-Ahmad A.
Pacing Clin Electrophysiol. 2008 Jan;31(1):78-82.
Early human experience with use of a deflectable fiberoptic endocardial visualization catheter to facilitate coronary sinus cannulation.
Anh DJ, Chen HA, Eversull CS, Mourlas NJ, Mead RH, Liem LB, Hsia HH, Wang PJ, Al-Ahmad A.
Heart Rhythm. 2006 Aug;3(8):875-8. Epub 2006 May 3.
Remote monitoring of implantable cardioverter defibrillators: a prospective analysis.
Schoenfeld MH, Compton SJ, Mead RH, Weiss DN, Sherfesee L, Englund J, Mongeon LR.
Pacing Clin Electrophysiol. 2004 Jun;27(6 Pt 1):757-63.
Dual AV nodal pathway physiology after injury with radiofrequency energy in a patient without a history of reentrant tachycardia.
Patrawala RA, Sharma AD, O’Neill G.
Pacing Clin Electrophysiol. 2001 Apr;24(4 Pt 1):512-4.
Prognostic significance of PVCs and resting heart rate.
Engel G, Cho S, Ghayoumi A, Yamazaki T, Chun S, Fearon WF, Froelicher VF.
Ann Noninvasive Electrocardiol. 2007 Apr;12(2):121-9.
Rapid diagnosis of myocardial injury with troponin T and CK-MB relative index.
Engel G, Rockson SG.
Mol Diagn Ther. 2007;11(2):109-16.
Novel predictor of prognosis from exercise stress testing: heart rate variability response to the exercise treadmill test.
Dewey FE, Freeman JV, Engel G, Oviedo R, Abrol N, Ahmed N, Myers J, Froelicher VF.
Am Heart J. 2007 Feb;153(2):281-8.
Premature ventricular contractions causing pacemaker-mediated tachycardia: a failure of postventricular atrial refractory period after premature ventricular contraction extension?
Witteles R, Engel G, Wang PJ, Al-Ahmad A.
Heart Rhythm. 2005 Dec;2(12):1389-90.
Electrocardiographic damage scores and cardiovascular mortality.
Richardson K, Engel G, Yamazaki T, Chun S, Froelicher VF.
Am Heart J. 2005 Mar;149(3):458-63.
Electrocardiographic arrhythmia risk testing.
Engel G, Beckerman JG, Froelicher VF, Yamazaki T, Chen HA, Richardson K, McAuley RJ, Ashley EA, Chun S, Wang PJ.
Curr Probl Cardiol. 2004 Jul;29(7):365-432. Review.
Computerized QT dispersion measurement and cardiovascular mortality in male veterans.
Shah BR, Yamazaki T, Engel G, Cho S, Chun SH, Froelicher VF.
Am J Cardiol. 2004 Feb 15;93(4):483-6.
Systematic review of the incidence of sudden cardiac death in the United States.
Kong MH, Fonarow GC, Peterson ED, Curtis AB, Hernandez AF, Sanders GD, Thomas KL, Hayes DL, Al-Khatib SM.
J Am Coll Cardiol. 2011 Feb 15;57(7):794-801.
Efficacy of adjunctive ablation of complex fractionated atrial electrograms and pulmonary vein isolation for the treatment of atrial fibrillation: a meta-analysis of randomized controlled trials.
Kong MH, Piccini JP, Bahnson TD.
Europace. 2011 Feb;13(2):193-204. Epub 2010 Oct 30.
Addressing disparities in sudden cardiac arrest care and the underutilization of effective therapies.
Kong MH, Peterson ED, Fonarow GC, Sanders GD, Yancy CW, Russo AM, Curtis AB, Sears SF Jr, Thomas KL, Campbell S, Carlson MD, Chiames C, Cook NL, Hayes DL, LaRue M, Hernandez AF, Lyons EL, Al-Khatib SM.
Am Heart J. 2010 Oct;160(4):605-18. Review.
Is rhythm-control superior to rate-control in patients with atrial fibrillation and diastolic heart failure?
Kong MH, Shaw LK, O’Connor C, Califf RM, Blazing MA, Al-Khatib SM.
Ann Noninvasive Electrocardiol. 2010 Jul;15(3):209-17.
Cost-effectiveness of implantable cardioverter defibrillators in patients >or=65 years of age.
Sanders GD, Kong MH, Al-Khatib SM, Peterson ED.
Am Heart J. 2010 Jul;160(1):122-31.
Surgical Maze procedure as a treatment for atrial fibrillation: a meta-analysis of randomized controlled trials.
Kong MH, Lopes RD, Piccini JP, Hasselblad V, Bahnson TD, Al-Khatib SM.
Cardiovasc Ther. 2010 Oct;28(5):311-26. doi: 10.1111/j.1755-5922.2010.00139.x. Review.
Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trials.
Piccini JP, Lopes RD, Kong MH, Hasselblad V, Jackson K, Al-Khatib SM.
Circ Arrhythm Electrophysiol. 2009 Dec;2(6):626-33. Epub.
Incidence and predictors of sudden cardiac death in patients with diastolic heart failure.
Al-Khatib SM, Shaw LK, O’Connor C, Kong M, Califf RM.
J Cardiovasc Electrophysiol. 2007 Dec;18(12):1231-5. Epub 2007 Sep 10.

Silicon Valley Cardiology is unique among private practice cardiology groups in having a continued interest in cutting edge clinical research to help advance our field. Our physicians remain engaged in clinical trials of new devices and procedures developed by industry, as well as original research from our own extensive clinical experience. In recent years we have been focused on perfecting the procedure to cure patients of their atrial fibrillation, and we have devoted resources in our practice to track our results in great detail. We believe this will allow us to serve our patients in as effective and safe a manner as possible, and that it is important to share our findings with other physicians. While there are many motivations for physicians to do what they do, the effort we put into this work should suggest that we remain dedicated to the advancement of knowledge in cardiology, and you, our patients, will ultimately benefit from that.

  • Physicians
  • Services
  • Atrial Fibrillation Center
  • Publications
  • New Patient?
  • Contact

© 2025 Silicon Valley Cardiology. All Rights Reserved. | Photography by Scott R. Kline | WordPress Website by HyperArts